Pharmacological treatment of neuropathic low backpain

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorThordarson, Hrafn
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2019-01-31T12:35:01Z
dc.date.available2019-01-31T12:35:01Z
dc.date.created2018-10-19
dc.description.abstractThe topic of my thesis is a discussion of neuropathic elements in low back pain, a very common condition, and the pharmacological treatment modalities in LBP both with and without neuropathy. Up to 84% of the population will present with low back pain at some point in their life and neuropathic components are associated with worse outcomes. Treatment of neuropathic pain with available drugs has been and continues to be a difficult subject were most patients do not experience full pain relief. Treatment options for LBP are varied, the nociceptive pain element of LBP can often be controlled with NSAIDs and a multidisciplinary approach to pain management, including group CBT, physiotherapy and good patient education and these should generally be considered the first-line treatment for LBP. Some novel approaches to the neuropathic element of LBP are promising, including tapentadol, capsaicin patches, and antidepressants, like TCAs and SNRIs. Some drugs effective in other neuropathic pain syndromes, like the anticonvulsants gabapentin and pregabalin have shown limited efficacy in neuropathic LBP even though they’re still commonly cited as first line therapies. Even so, our measure of successful treatment in CLBP typically only signifies a reduction in everyday pain levels of over 30%.hu_HU
dc.description.correctorLB
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent28hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/263476
dc.language.isoenhu_HU
dc.subjectBack Painhu_HU
dc.subjectLow Back Painhu_HU
dc.subjectNeuropathyhu_HU
dc.subjectPharmacologyhu_HU
dc.subjectTreatmenthu_HU
dc.subjectRadiculopathyhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titlePharmacological treatment of neuropathic low backpainhu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)